LifeBio Memory Digital Reminiscence Platform

Last updated: August 7, 2024
Sponsor: Benjamin Rose Institute on Aging
Overall Status: Completed

Phase

N/A

Condition

Dementia

Learning Disorders

Mild Cognitive Impairment

Treatment

LifeBio Memory

Clinical Study ID

NCT04769466
1908-216
  • Ages 18-112
  • All Genders

Study Summary

Non-pharmacological interventions and person-centered care strategies are important elements of care for people with Alzheimer's disease and related dementias. Life story work, which uses written and oral life histories to elicit conversation and memories, is an effective intervention for individuals with dementia; however, because of the time-consuming nature of generating useful life story materials, has not been widely implemented in nursing homes and other care environments. LifeBio Inc. will develop an easy-to-use reminiscence therapy platform - LifeBio MemoryTM - with a novel machine-learning-based application that converts speech to text and generates life stories to serve as an interactive tool to cultivate communication between people living with dementia and their family and caregivers.

Eligibility Criteria

Inclusion

Inclusion Criteria (Staff):

  • Work within a residential care facility participating in the study

  • Speak and read English

  • Able to provide own transportation to and from interviews with residents

Inclusion Criteria (Residents

  • Must reside within a participating residential care facility

  • Must be at least 55 years of Age

  • Must speak and read English

  • Have a Dementia diagnosis

  • Have a Score of at least 15 on the Mini Mental State Examination

Exclusion Criteria (Residents)

  • Residents will be excluded from the study if they show signs of rapid cognitive decline or physical deterioration over the last 6 months, as evidence by information gained during screening.

Study Design

Total Participants: 160
Treatment Group(s): 1
Primary Treatment: LifeBio Memory
Phase:
Study Start date:
March 22, 2022
Estimated Completion Date:
April 30, 2024

Study Description

This project offers the unique and timely opportunity to evaluate the feasibility, acceptability, and efficacy of LifeBio Memory's effectiveness as a solution for improving quality of life and quality of care for older adults in long-term care settings, as well as relationships with staff caregivers. This project will implement the the newly developed LifeBio Memory platform and train caregivers in X sites across the state of Ohio, with X residents and X staff participating in a feasibility trial. The program will be evaluated using three waves of data collection from staff during training and throughout implementation, as well as pre-post resident data to evaluate the effectiveness of the new intervention.

The LifeBio Memory platform addresses the need for an intuitive, artificial intelligence-driven solution to the traditionally labor-intensive process of collecting, sharing, and celebrating the life stories of older adults, as well as the development of tools for staff caregivers to enhance person-centered care practices and care-planning. It has great potential for improving psychosocial outcomes for participants, enhancing relationships between care staff and residents, and a cost-effective way to identify ways in which life stories can be used to provide a foundation for preference-based, personalized care.

Residents will be interviewed at baseline, then again at follow-up (4 weeks later), staff members being trained to utilize the LifeBio Memory application and provide feedback on the materials, as well as completed a survey at baseline, again at follow-up

Connect with a study center

  • Benjamin Rose Institute on Aging

    Cleveland, Ohio 44120
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.